The world’s population has increased by more than 2.6-fold in the last 60 years. The growing trend continues – projections indicate that the number of people living on our planet will grow to 9 billion by 2037 from 8 billion in 2022. These numbers underscore the need for considering family planning; however, there have been limited breakthroughs in contraception in recent decades. Specifically for men, there are no oral contraceptive pills available. In a study...

Sibylla’s PPI-FIT technology joins with MD Anderson’s drug development resources and expertise to create protein-folding interfering degraders as cancer therapies   The University of Texas MD Anderson Cancer Center and Sibylla Biotech recently announced a strategic collaboration agreement to discover and develop novel small-molecule cancer therapies known as folding interfering degraders (FIDs), which disrupt the proper folding of target proteins and lead to their degradation.   Under the agreement, Sibylla and MD Anderson will jointly conduct discovery and development work from...